Bruce E. Lewis
  • Professor
  • Cardiology
Heart Disease, Vascular Disease, Abdominal Aortic Aneurysm
Board Certifications
  • Cardiovascular Disease - Subspecialty Cert: AM Board of Internal Medicine
  • Internal Medicine - General Cert: AM Board of Internal Medicine
  • Interventional Cardiology - Subspecialty Cert: AM Board of Internal Medicine

ATA Practice Guidelines for Live, On Demand Primary and Urgent CareGough,F.; Budhrani,S.; Cohn,E.; Dappen,A.; Leenknecht,C.; Lewis,B.; Mulligan,D. A.; Randall,D.; Rheuban,K.; Roberts,L.; Shanahan,T. J.; Webster,K.; Krupinski,E. A.; Bashshur,R.; Bernard,J.Telemedicine journal and e-health : the official journal of the American Telemedicine Association 2015 ; ( ):

Comparison of primary percutaneous coronary intervention in patients with st-elevation myocardial infarction during and prior to availability of an in-house STEMI system: Early experience and intermediate outcomes of the HARRT program for achieving routine d2b times <60 minutesNguyen,B.; Fennessy,M.; Leya,F.; Nowak,W.; Ryan,M.; Freeberg,S.; Gill,J.; Dieter,R. S.; Steen,L.; Lewis,B.; Cichon,M.; Probst,B.; Jarotkiewicz,M.; Wilber,D.; Lopez,J. J.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2014 ; ( ):

The increasing incidence of thromboembolic events among hospitalized patients with inflammatory bowel diseaseKuy,S.; Dua,A.; Chappidi,R.; Seabrook,G.; Brown,K. R.; Lewis,B.; Rossi,P. J.; Lee,C. J.Vascular 2014 ; ( ):

An open label, non-randomized, prospective clinical trial evaluating the immunogenicity of branded enoxaparin versus biosimilars in healthy volunteers.Gomes,M.; Ramacciotti,E.; Hoppensteadt,D.; Walenga,J. M.; Lewis,B.; Thethi,I.; Fareed,J.Clinical & Applied Thrombosis/Hemostasis 2011 ;17(1):66-69

Usefulness of wide pulse pressure as a predictor of poor outcome after renal artery angioplasty and stenting.Dieter,R. S.; Darki,A.; Nanjundappa,A.; Chhokar,V. S.; Khadim,G.; Morshedi-Meibodi,A.; Freihage,J. H.; Steen,L.; Lewis,B.; Leya,F.American Journal of Cardiology 2009 ;104(5):732-734

Argatroban in percutaneous coronary indicationsIqbal,O.; Adiguzel,C.; Lewis,B. E.; Cunanan,J.; Fareed,J.Seminars in Thrombosis and Hemostasis 2008 ;34( ):75

Predictors of clinical outcome in patients with heparin-induced thrombocytopenia treated with direct thrombin inhibition.Kelton,J. G.; Hursting,M. J.; Heddle,N.; Lewis,B. E.Blood Coagulation & Fibrinolysis 2008 ;19(6):471-475

Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudinRamana,R. K.; Lewis,B. E.Vascular Health & Risk Management 2008 ;4(3):493-505

Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft diseaseRamana,R. K.; Ronan,A.; Cohoon,K.; Homan,D.; Sutherland,J.; Steen,L.; Liu,J.; Loeb,H.; Lewis,B. E.Catheterization & Cardiovascular Interventions 2008 ;71(7):886-893

Femoral angiogram prior to arteriotomy closure device does not reduce vascular complications in patients undergoing cardiac catheterization.Ramana,R. K.; Singh,A.; Dieter,R. S.; Moran,J. F.; Steen,L.; Lewis,B. E.; Leya,F.Journal of interventional cardiology 2008 ;21(2):204-208

Utility of BNP in differentiating constrictive pericarditis from restrictive cardiomyopathy in patients with renal insufficiency.Reddy,P. R.; Dieter,R. S.; Das,P.; Steen,L. H.; Lewis,B. E.; Leya,F. S.Journal of cardiac failure 2007 ;13(8):668-671

The influence of low (81 mg) versus high (325 mg) doses of ASA on the incidence of sirolimus-eluting stent thrombosis.Joyal,D.; Freihage,J. H.; Cohoon,K.; Tempelhof,M.; Leya,F.; Dieter,R. S.; Steen,L.; Lewis,B.; Arab,D.Journal of Invasive Cardiology 2007 ;19(7):291-294

Presence of asymmetric dimethylarginine gradients across high-grade lesions in patients with coronary artery disease.Joyal,D.; Leya,F.; Al Chekakie,M. O.; Arab,D.; Dieter,R. S.; Morshedi-Meibodi,A.; Lewis,B.; Steen,L.; Fareed,J.; Hoppenstead,D.; Akar,J. G.Coronary artery disease 2007 ;18(6):471-475

Troponin I levels in patients with preeclampsia.Joyal,D.; Leya,F.; Koh,M.; Besinger,R.; Ramana,R.; Kahn,S.; Jeske,W.; Lewis,B.; Steen,L.; Mestril,R.; Arab,D.American Journal of Medicine 2007 ;120(9):819.e13-819.e14

Invasive assessment of mitral regurgitation: comparison of hemodynamic parameters.Freihage,J. H.; Joyal,D.; Arab,D.; Dieter,R. S.; Loeb,H. S.; Steen,L.; Lewis,B.; Liu,J. C.; Leya,F.Catheterization & Cardiovascular Interventions 2007 ;69(2):303-312

Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopeniaLewis,B. E.; Hursting,M. J.Expert Review of Cardiovascular Therapy 2007 ;5(1):57-68

Clinical experience with rotational atherectomy in patients with severe left ventricular dysfunctionRamana,R. K.; Joyal,D.; Arab,D.; Dieter,R. S.; Steen,L.; Lewis,B.; Leya,F.Journal of Invasive Cardiology 2006 ;18(11):514-518

Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopeniaLewis,B. E.; Wallis,D. E.; Hursting,M. J.; Levine,R. L.; Leya,F.Chest 2006 ;129(6):1407-1416

Thiazolidinediones do not reduce target vessel revascularization in diabetic patients undergoing percutaneous coronary intervention.Cho,L.; Lewis,B. E.; Steen,L. H.; Leya,F. S.Cardiology 2005 ;104(2):97-100

The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy.Leya,F. S.; Arab,D.; Joyal,D.; Shioura,K. M.; Lewis,B. E.; Steen,L. H.; Cho,L.Journal of the American College of Cardiology 2005 ;45(11):1900-1902

Coronary artery perforation during percutaneous coronary intervention: incidence and outcomes in the new interventional eraRamana,R. K.; Arab,D.; Joyal,D.; Steen,L.; Cho,L.; Lewis,B.; Liu,J.; Loeb,H.; Leya,F.Journal of Invasive Cardiology 2005 ;17(11):603-605

Antiplatelet therapy in anticoagulated patients requiring coronary interventionArab,D.; Lewis,B.; Cho,L.; Steen,L.; Joyal,D.; Leya,F.Journal of Invasive Cardiology 2005 ;17(10):549-554

Use of lepirudin during percutaneous vascular interventions in patients with heparin-induced thrombocytopeniaCochran,K.; DeMartini,T. J.; Lewis,B. E.; O'Brien,J.; Steen,L. H.; Grassman,E. D.; Leya,F.Journal of Invasive Cardiology 2003 ;15(11):617-621

New catheter design for cannulation of the anomalous right coronary artery arising from the left sinus of valsalva.Qayyum,U.; Leya,F.; Steen,L.; Sochanski,M.; Grassman,E.; Cho,L.; Lewis,B.Catheterization & Cardiovascular Interventions 2003 ;60(3):382-388

Global anticoagulant effects of a synthetic anti-factor Xa inhibitor (DX-9065a): implications for interventional use.Tobu,M.; Iqbal,O.; Ma,Q.; Schultz,C.; Jeske,W.; Hoppensteadt,D.; Lewis,B.; Fareed,D.; Fareed,J.Clinical & Applied Thrombosis/Hemostasis 2003 ;9(1):1-17

Patency of coronary artery bypass grafts in patients with heparin-induced thrombocytopeniaLiu,J. C.; Lewis,B. E.; Steen,L. H.; Grassman,E. D.; Bakhos,M.; Blakeman,B.; Wrona,L.; Leya,F.The American Journal of Cardiology 2002 ;89(8):979-981

Bleeding complications with glycoprotein IIb/IIIa inhibitorsIqbal,O.; Walenga,J. M.; Lewis,B. E.; Bakhos,M.Drugs of today (Barcelona, Spain : 1998) 2000 ;36(8):503-514

Medical School
  • Rush Medical College of Rush University
  • Rush-Presbyterian-St. Luke's Medical Center, Internal Medicine: General
  • Loyola University Medical Center, Cardiology
  • Spanish
  • Basketball
  • Tennis
  • Gardening